These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

167 related items for PubMed ID: 15566416

  • 1. Clinical implications of migraine in systemic lupus erythematosus: relation to cumulative organ damage.
    Appenzeller S, Costallat LT.
    Cephalalgia; 2004 Dec; 24(12):1024-30. PubMed ID: 15566416
    [Abstract] [Full Text] [Related]

  • 2. [Migraine in SLE: role of antiphospholipid antibodies and Raynaud's phenomenon].
    Annese V, Tomietto P, Venturini P, D'Agostini S, Ferraccioli G.
    Reumatismo; 2006 Dec; 58(1):50-8. PubMed ID: 16639488
    [Abstract] [Full Text] [Related]

  • 3. Prevalence and factors associated with headache in patients with systemic lupus erythematosus.
    Weder-Cisneros ND, Téllez-Zenteno JF, Cardiel MH, Guibert-Toledano M, Cabiedes J, Velásquez-Paz AL, García-Ramos G, Cantú C.
    Cephalalgia; 2004 Dec; 24(12):1031-44. PubMed ID: 15566417
    [Abstract] [Full Text] [Related]

  • 4. The effect of menopause on disease activity in systemic lupus erythematosus.
    Urowitz MB, Ibañez D, Jerome D, Gladman DD.
    J Rheumatol; 2006 Nov; 33(11):2192-8. PubMed ID: 16981295
    [Abstract] [Full Text] [Related]

  • 5. Predictors of neuropsychiatric damage in systemic lupus erythematosus: data from the Maryland lupus cohort.
    Mikdashi J, Handwerger B.
    Rheumatology (Oxford); 2004 Dec; 43(12):1555-60. PubMed ID: 15342927
    [Abstract] [Full Text] [Related]

  • 6. Elevated levels of soluble fractalkine in active systemic lupus erythematosus: potential involvement in neuropsychiatric manifestations.
    Yajima N, Kasama T, Isozaki T, Odai T, Matsunawa M, Negishi M, Ide H, Kameoka Y, Hirohata S, Adachi M.
    Arthritis Rheum; 2005 Jun; 52(6):1670-5. PubMed ID: 15934075
    [Abstract] [Full Text] [Related]

  • 7. Effect of disease activity and damage on quality of life in patients with systemic lupus erythematosus: a 2-year prospective study.
    Mok CC, Ho LY, Cheung MY, Yu KL, To CH.
    Scand J Rheumatol; 2009 Jun; 38(2):121-7. PubMed ID: 18991189
    [Abstract] [Full Text] [Related]

  • 8. General and specific factors associated with severity of cognitive impairment in systemic lupus erythematosus.
    Tomietto P, Annese V, D'agostini S, Venturini P, La Torre G, De Vita S, Ferraccioli GF.
    Arthritis Rheum; 2007 Dec 15; 57(8):1461-72. PubMed ID: 18050188
    [Abstract] [Full Text] [Related]

  • 9. Greater accrual damage in late-onset systemic lupus erythematosus: a long-term follow-up study.
    Appenzeller S, Pereira DA, Costallat LT.
    Lupus; 2008 Nov 15; 17(11):1023-8. PubMed ID: 18852227
    [Abstract] [Full Text] [Related]

  • 10. Disease course in systemic lupus erythematosus: changes in health status, disease activity, and organ damage after 2 years.
    Gilboe IM, Kvien TK, Husby G.
    J Rheumatol; 2001 Feb 15; 28(2):266-74. PubMed ID: 11246660
    [Abstract] [Full Text] [Related]

  • 11. Increased arterial stiffness correlated with disease activity in systemic lupus erythematosus.
    Shang Q, Tam LS, Li EK, Yip GW, Yu CM.
    Lupus; 2008 Dec 15; 17(12):1096-102. PubMed ID: 19029277
    [Abstract] [Full Text] [Related]

  • 12. Somatic and psychological features of headache in systemic lupus erythematosus.
    Omdal R, Waterloo K, Koldingsnes W, Husby G, Mellgren SI.
    J Rheumatol; 2001 Apr 15; 28(4):772-9. PubMed ID: 11327249
    [Abstract] [Full Text] [Related]

  • 13. Migraine is frequent in patients with systemic lupus erythematosus: a case-control study.
    Tjensvoll AB, Harboe E, Gøransson LG, Beyer MK, Greve OJ, Herigstad A, Kvaløy JT, Omdal R.
    Cephalalgia; 2011 Mar 15; 31(4):401-8. PubMed ID: 20974597
    [Abstract] [Full Text] [Related]

  • 14. [Significance of damage index in predicting systemic lupus erythematosus outcome].
    Tarasova IA, Ivanova MM, Zhorniak AP, Nasonova VA.
    Ter Arkh; 2003 Mar 15; 75(1):59-62. PubMed ID: 12652960
    [Abstract] [Full Text] [Related]

  • 15. Disease activity, damage and survival in Mexican patients with acute severe systemic lupus erythematosus.
    Zonana-Nacach A, Yañez P, Jiménez-Balderas FJ, Camargo-Coronel A.
    Lupus; 2007 Mar 15; 16(12):997-1000. PubMed ID: 18042596
    [Abstract] [Full Text] [Related]

  • 16. Pulmonary hypertension in systemic lupus erythematosus: clinical association and survival in 18 patients.
    Li EK, Tam LS.
    J Rheumatol; 1999 Sep 15; 26(9):1923-9. PubMed ID: 10493670
    [Abstract] [Full Text] [Related]

  • 17. Elevated levels of serum soluble Fas are associated with organ and tissue damage in systemic lupus erythematosus among Chinese.
    Hao JH, Ye DQ, Zhang GQ, Liu HH, Dai H, Huang F, Pan FM, Su H, Dong MX, Chen H, Wang Q, Zhang XJ.
    Arch Dermatol Res; 2006 Jan 15; 297(7):329-32. PubMed ID: 16328345
    [Abstract] [Full Text] [Related]

  • 18. Predictors of damage progression in Portuguese patients with systemic lupus erythematosus.
    Santos MJ, Vinagre F, Nero P, Barcelos F, Barcelos A, Rodrigues AM, de Matos AA, Silva C, Miranda L, Capela S, Marques A, Branco J, da Silva JC.
    Ann N Y Acad Sci; 2009 Sep 15; 1173():822-8. PubMed ID: 19758234
    [Abstract] [Full Text] [Related]

  • 19. SLICC/ACR Damage Index in Afro-Caribbean patients with systemic lupus erythematosus: changes in and relationship to disease activity, corticosteroid therapy, and prognosis.
    Nossent JC.
    J Rheumatol; 1998 Apr 15; 25(4):654-9. PubMed ID: 9558165
    [Abstract] [Full Text] [Related]

  • 20. Systemic lupus erythematosus in a multiethnic US cohort, XXXVII: association of lymphopenia with clinical manifestations, serologic abnormalities, disease activity, and damage accrual.
    Vilá LM, Alarcón GS, McGwin G, Bastian HM, Fessler BJ, Reveille JD, Lumina Study Group.
    Arthritis Rheum; 2006 Oct 15; 55(5):799-806. PubMed ID: 17013840
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.